Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study

INTRODUCTION: Preterm birth complicates >15 million pregnancies annually worldwide. In many countries, women who present with signs of preterm labour are treated with tocolytics for 48 hours. Although this delays birth, it has never been shown to improve neonatal outcome. In 2015, the WHO stated...

Descripción completa

Detalles Bibliográficos
Autores principales: Klumper, Job, Breebaart, Wouter, Roos, Carolien, Naaktgeboren, Christiana A, van der Post, Joris, Bosmans, Judith, van Kaam, Anton, Schuit, Ewoud, Mol, Ben W, Baalman, Jelle, McAuliffe, Fionnuala, Thornton, Jim, Kok, Marjolein, Oudijk, Martijn A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887072/
https://www.ncbi.nlm.nih.gov/pubmed/31772083
http://dx.doi.org/10.1136/bmjopen-2019-029101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887072/
https://www.ncbi.nlm.nih.gov/pubmed/31772083
http://dx.doi.org/10.1136/bmjopen-2019-029101

Ejemplares similares